Drug General Information
Drug ID
D0Q0YC
Former ID
DNC004851
Drug Name
2-(4-Propyl-piperazin-1-yl)-quinoline
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527370]
Structure
Download
2D MOL

3D MOL

Formula
C15H19N3
Canonical SMILES
CCN1CCN(CC1)C2=NC3=CC=CC=C3C=C2
InChI
1S/C15H19N3/c1-2-17-9-11-18(12-10-17)15-8-7-13-5-3-4-6-14(13)16-15/h3-8H,2,9-12H2,1H3
InChIKey
HEWVIFVVKWCRML-UHFFFAOYSA-N
PubChem Compound ID
Target and Pathway
Target(s) Histamine H3 receptor Target Info Inhibitor [527370]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Histamine receptors
G alpha (i) signalling events
WikiPathways Monoamine Transport
GPCRs, Class A Rhodopsin-like
GPCR ligand binding
GPCR downstream signaling
References
Ref 527370J Med Chem. 2005 Jan 13;48(1):306-11.2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.
Ref 527370J Med Chem. 2005 Jan 13;48(1):306-11.2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.